534 related articles for article (PubMed ID: 29305258)
21. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W
J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879
[TBL] [Abstract][Full Text] [Related]
22. Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro.
Wang MX; Zhao JX; Meng YJ; Di TT; Xu XL; Xie XJ; Lin Y; Zhang L; Wang N; Li P; Wang Y
Life Sci; 2018 Aug; 207():90-104. PubMed ID: 29859222
[TBL] [Abstract][Full Text] [Related]
23. Involvement of high mobility group box-1 in imiquimod-induced psoriasis-like mice model.
Chen T; Fu LX; Guo ZP; Yin B; Cao N; Qin S
J Dermatol; 2017 May; 44(5):573-581. PubMed ID: 27943400
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
Sun J; Dou W; Zhao Y; Hu J
Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):17-24. PubMed ID: 24286371
[TBL] [Abstract][Full Text] [Related]
25. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
Palomo J; Troccaz S; Talabot-Ayer D; Rodriguez E; Palmer G
PLoS One; 2018; 13(3):e0194667. PubMed ID: 29554104
[TBL] [Abstract][Full Text] [Related]
26. Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation.
Sun Y; Zhang J; Huo R; Zhai T; Li H; Wu P; Zhu X; Zhou Z; Shen B; Li N
Int Immunopharmacol; 2015 Feb; 24(2):392-399. PubMed ID: 25576402
[TBL] [Abstract][Full Text] [Related]
27. High-fat diet exacerbates imiquimod-induced psoriasis-like dermatitis in mice.
Higashi Y; Yamakuchi M; Fukushige T; Ibusuki A; Hashiguchi T; Kanekura T
Exp Dermatol; 2018 Feb; 27(2):178-184. PubMed ID: 29247486
[TBL] [Abstract][Full Text] [Related]
28. Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response.
Hau CS; Kanda N; Tada Y; Shibata S; Uozaki H; Fukusato T; Sato S; Watanabe S
J Dermatol; 2016 Jul; 43(7):785-94. PubMed ID: 26702876
[TBL] [Abstract][Full Text] [Related]
29. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
Sun J; Zhao Y; Hu J
PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
[TBL] [Abstract][Full Text] [Related]
30. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
[TBL] [Abstract][Full Text] [Related]
31. The vitamin D
Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S
J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055
[TBL] [Abstract][Full Text] [Related]
32. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
[TBL] [Abstract][Full Text] [Related]
33. Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis.
Swindell WR; Michaels KA; Sutter AJ; Diaconu D; Fritz Y; Xing X; Sarkar MK; Liang Y; Tsoi A; Gudjonsson JE; Ward NL
Genome Med; 2017 Mar; 9(1):24. PubMed ID: 28279190
[TBL] [Abstract][Full Text] [Related]
34. IL-23/IL-17 immune axis mediates the imiquimod-induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF-κB pathway in macrophages and keratinocytes.
Chen WC; Wen CH; Wang M; Xiao ZD; Zhang ZZ; Wu CL; Wu R
Kaohsiung J Med Sci; 2023 Aug; 39(8):789-800. PubMed ID: 37098777
[TBL] [Abstract][Full Text] [Related]
35. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice.
Liu Z; Liu H; Xu P; Yin Q; Wang Y; Opoku YK; Yang J; Song L; Sun X; Zhang T; Yu D; Wang X; Ren G; Li D
Biomed Pharmacother; 2018 Dec; 108():1425-1434. PubMed ID: 30372845
[TBL] [Abstract][Full Text] [Related]
36. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice.
Deng G; Chen W; Wang P; Zhan T; Zheng W; Gu Z; Wang X; Ji X; Sun Y
Int Immunopharmacol; 2019 Sep; 74():105682. PubMed ID: 31203155
[TBL] [Abstract][Full Text] [Related]
38. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A
J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487
[TBL] [Abstract][Full Text] [Related]
39.
Fujii K; Yamamoto Y; Mizutani Y; Saito K; Seishima M
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752186
[No Abstract] [Full Text] [Related]
40. Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state.
Jin SP; Koh SJ; Yu DA; Kim MW; Yun HT; Lee DH; Yoon HS; Cho S; Park HS
Exp Dermatol; 2018 Jan; 27(1):43-49. PubMed ID: 28677206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
